Clinical Trial Update: Sunitinib in Treating Patients With Brain Metastases Caused by Kidney Cancer or Melanoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating sunitinib for brain metastases caused by kidney cancer or melanoma; the study is completed with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Cancer
• Melanoma

Drugs mentioned

• Sutent (sunitinib)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Kidney Cancer, Melanoma (Skin) | Phase 2 | Status: COMPLETED | Results posted: 2015-12-30